-transparent.png){kind=logo}
Seventy neonatal to adolescent general surgical patients were studied to create an individual dose-response curve for the long-acting neuromuscular blocking agents, alcuronium and d-tubocurarine. The mean (SEM) ED95 of alcuronium was 196 (9), 271 (13) and 243 (8) micrograms/kg in infants, children and adolescents, respectively (P less than 0.01). d-tubocurarine showed a similar age dependent dose-response relationship. ED95 doses were 414 (40), 499 (41) and 445 (31) micrograms/kg, respectively. The onset time (time from intravenous administration to maximal effect) following equipotent dosages was 40-50% shorter in infants than in children or adolescents (1.5 vs 2.7 minutes, P less than 0.05).
O A Meretoja, and
T C Brown, and
D Clare
January 1969,
Acta anaesthesiologica Scandinavica. Supplementum,
O A Meretoja, and
T C Brown, and
D Clare
February 1979,
Anaesthesia and intensive care,
O A Meretoja, and
T C Brown, and
D Clare
September 1982,
Anesthesiology,
O A Meretoja, and
T C Brown, and
D Clare
October 1979,
Anesthesiology,
O A Meretoja, and
T C Brown, and
D Clare
February 1993,
Acta anaesthesiologica Scandinavica,
O A Meretoja, and
T C Brown, and
D Clare
September 1984,
Anesthesia and analgesia,
O A Meretoja, and
T C Brown, and
D Clare
July 1978,
Der Anaesthesist,
O A Meretoja, and
T C Brown, and
D Clare
October 1972,
Anaesthesia,
O A Meretoja, and
T C Brown, and
D Clare
March 2010,
American family physician,
O A Meretoja, and
T C Brown, and
D Clare
April 1988,
Anesthesiology,
